Acute Leukemia Clinical Endpoints Will Be Topic Of FDA Public Workshop
This article was originally published in The Pink Sheet Daily
The meeting is part of FDA's series on cancer clinical trial endpoints. The workshop, which will address clinical endpoints for acute lymphocytic and myeloid leukemia, will be held June 24 in Washington, D.C.
You may also be interested in...
Presenters at an FDA public workshop on prostate cancer clinical trial endpoints agree neither PSA nor bone scan alone would be an appropriate endpoint. PSA could be used to confirm a bone scan reading, Office of Cellular, Tissue & Gene Therapies Oncology Group Leader Hirschfeld suggests.
The company is planning a direct-to-consumer education campaign to inform the public about the importance of vaccination.
The company showcased its pipeline in a two-day virtual meeting, trying to convince investors the long-term potential is undervalued.